Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins. - Wikidata - wikimedia - TriplyDB

Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.

Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.

http://www.wikidata.org/entity/Q35192915

about

Bottlenecks in HIV-1 transmission: insights from the study of founder viruses The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder Virus Recent Insights into the HIV/AIDS Pandemic.Survivors Remorse: antibody-mediated protection against HIV-1.Passive immunization against HIV/AIDS by antibody gene transfer.Induction of a Tier-1-like Phenotype in Diverse Tier-2 Isolates by Agents that Guide HIV-1 Env to Perturbation-sensitive, Non-native States.An evaluation of phylogenetic methods for reconstructing transmitted HIV variants using longitudinal clonal HIV sequence data.Which Antibody Functions are Important for an HIV Vaccine?Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes.Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.Phenotypic properties of transmitted founder HIV-1 Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection.Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.HIV-1 target cells in the CNS.HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection.Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes.Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.Immune evasion activities of accessory proteins Vpu, Nef and Vif are conserved in acute and chronic HIV-1 infection.Association of enhanced HIV-1 neutralization by a single Y681H substitution in gp41 with increased gp120-CD4 interaction and macrophage infectivity.Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7 The Molecular Characterization of Intestinal Explant HIV Infection Using Polymerase Chain Reaction-Based Techniques.Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model.Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction.HIV transmission Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5.Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication Macrophages sustain HIV replication in vivo independently of T cells Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1

P2860

Q28082862-C3EE96FC-A905-47A1-9A4E-ED6A8366CC92 Q28302792-39518965-3793-4AC4-B112-42358A9F9B13 Q28482493-137CB7A7-572E-4266-BB6E-E65654E9732C Q28551914-6892E0AF-5379-47E3-910A-6F373B5AC00C Q30235024-0917EF49-EE55-498E-B519-0304267527D0 Q30238730-67A74027-C747-47FC-8BC9-05260406B85F Q30358434-3F2E6021-9355-44F6-9F3D-54EEAEB22DBB Q30401836-204C51C2-88CD-4926-99B9-4447E0456632 Q30781299-4D7CB99A-7744-4E48-9060-0CDDEE96A97B Q33772637-BF37CE72-6CC5-4059-BCC0-B9BB387222B0 Q34262089-73811FF7-E675-4E9C-B142-FA519F17A8A7 Q34267043-CC320D1F-599F-48C7-96B5-AA3E8A8B0154 Q34336058-6AAE6DF6-4F4F-482D-BDFD-A5CA57824208 Q34407843-79E68157-7FC7-4307-92DF-E5DA1168FFAE Q34503200-17DAF5FE-CAB0-4F5C-BC76-6694123D39D3 Q34593647-11CE258F-CD90-4E74-85D6-2A7BF10B18DF Q34620235-F8655062-3114-4967-AD12-F659C8997AF9 Q34721189-0F0DB858-AB1E-408A-984F-56B370A8C1E9 Q35009308-D7FC52C8-E385-479D-8DC5-EB4BE0EAA673 Q35110976-37B6AD34-7593-4AC2-8FA4-E5F5FAF0353E Q35196509-E0FDD309-BA88-431C-B67A-3498848F2471 Q35216488-39F352F2-5AC6-4A27-8C54-1E61C4FD7DF4 Q35219829-BA9E0EE0-5DE5-4B0C-99DD-6DAFFD945CD1 Q35694015-D1083977-4B79-4E85-A698-6714B94357C4 Q35778333-46544B51-4339-43FE-A5F3-8CF37CF5AF84 Q35826158-B05113D8-F152-4548-B27A-3D33DCBF0783 Q35855904-BF2780BD-4B86-43A1-8ABA-2A31F615CE23 Q35956940-DD13809A-043A-49A2-8AE1-E69DCF46663D Q36000722-30E453C7-250D-44CD-8F6E-0FBCCAC0AD41 Q36078433-B6C579E4-DF5A-4058-89A9-84B984F1327A Q36081789-1F2A25A2-E12C-4753-B584-4D2ADE741B7C Q36337888-021F4F19-37E6-4DBC-8BCC-51937AB06F14 Q36343848-220E278A-208A-45C6-AB42-0762F52C4FA4 Q36526615-B1230650-7E41-4E72-84B2-9FA3CF79CBA5 Q36532973-D7B1E086-9A96-4480-85E9-605AE12A0CEC Q36588632-8582652A-CED2-48DC-A642-380DA497945F Q36607127-7B102E34-C349-4C6E-AF30-287F90614FB9 Q36612971-4773310A-50FB-4420-BB6D-1691A582F821 Q36737917-96A5362B-774C-45D0-BBCE-DE8E72E6E13C Q36760169-DD36EBF9-B05F-412C-8BE7-2BE7B2E8A17D

P2860

Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.

http://www.wikidata.org/entity/Q35192915

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Phenotypic and immunologic com ...... HIV-1 envelope glycoproteins.

@ast

Phenotypic and immunologic com ...... HIV-1 envelope glycoproteins.

@en

type

label

Phenotypic and immunologic com ...... HIV-1 envelope glycoproteins.

@ast

Phenotypic and immunologic com ...... HIV-1 envelope glycoproteins.

@en

prefLabel

Phenotypic and immunologic com ...... HIV-1 envelope glycoproteins.

@ast

Phenotypic and immunologic com ...... HIV-1 envelope glycoproteins.

@en

P1433

Q35192915-434EE385-30DB-49EB-A62C-DACAF9BF8D0B

P1476

Q35192915-0AAE6545-62AD-44E0-8DA5-B42D0386EB1B

P2093

Q35192915-0547F5C1-B9B3-4A9D-A780-DBCB31233CB2

Q35192915-1580BF89-6C85-481A-A331-20719791BAE5

Q35192915-53DA1306-7E83-4DE7-8239-9D63B52AF243

Q35192915-60C9A47C-4F11-4CD1-8A11-61ED2B2D0C64

Q35192915-6A64EC1F-2854-437D-88D3-EABFC511F5F1

Q35192915-6E2B7D7E-D8C2-4412-866F-67B2D45E8BE0

Q35192915-CD560BF8-F6C2-4262-B3D6-753DC0E0D911

P2860

Q35192915-0021C235-BD60-4B44-812C-DF38FE5698E6

Q35192915-004E8D30-6F2C-4E2F-92D8-0F5E0E3433AC

Q35192915-02CFD309-F49D-4994-8A47-2053452117B8

Q35192915-04B6FF8F-DF40-4875-AF67-2442313917C3

Q35192915-08F39509-58D1-4FDF-BA8A-1DE11B11A005

Q35192915-0A58007A-A40C-41A3-90F5-B22F531624E6

Q35192915-0BA37D7D-BC22-46E3-AAAC-31B7EB8E179B

Q35192915-0FAFEEE9-41D4-4628-A8DA-E5306FD37C43

Q35192915-1116EFF8-09F2-4672-B145-97FFBB0E0EB0

Q35192915-12CBFABA-75E3-48FA-A319-E46350D443E6

P304

Q35192915-5B2F0AC3-97FE-4B4F-A8D7-318D0FB695FE

P31

Q35192915-9354E68C-EA97-4F02-8B03-97CB341576E9

P356

Q35192915-1F0CC878-4921-4FEF-A36A-714039B134AD

P407

Q35192915-CA156E31-83C1-4440-81CC-261961871571

P433

Q35192915-294CA59E-91D1-4ECC-91E8-2266FB58E372

P478

Q35192915-677DE6EF-0167-4134-988D-95A96E08C998

P50

Q35192915-15C27064-8EBA-4D97-BBFC-D9A4DBF73753

Q35192915-62B9BEBE-59F9-43F4-817E-5F08912B4C1D

Q35192915-77802029-F24E-4A9C-989A-C7352FE328B5

Q35192915-849BA5EB-A5C2-4A54-8C08-9BEDFE7D2E57

Q35192915-A252A469-5123-4BCA-82D9-C5E835C7743B

Q35192915-BABA15E2-AF7A-4FC6-9F40-5E9D34CFCCED

Q35192915-DE6D75CD-4462-4F7B-BFEC-D9036536A656

Q35192915-F914036A-BBD5-4EB2-BE11-B39ADA605549

P577

Q35192915-0E4574D2-88DF-4B93-BE94-BDB01985B5C6

P5875

Q35192915-30833AE2-C5D4-48A3-B8DF-3E4119A6282E

P698

Q35192915-B1997A8D-C03B-4280-99F5-11880F3BF127

P921

Q35192915-AB1C3157-35EF-40D2-9821-018368F87F92

P932

Q35192915-35A4D156-0DB2-47E5-BA95-43EBB8EC7AB6

P356

P1433

Journal of Virology

P1476

Phenotypic and immunologic com ...... HIV-1 envelope glycoproteins.

@en

P2093

Elizabeth A Henning

http://www.w3.org/2001/XMLSchema#string

Jason A Wojcechowskyj

http://www.w3.org/2001/XMLSchema#string

Jennifer M Pfaff

http://www.w3.org/2001/XMLSchema#string

John C Tilton

http://www.w3.org/2001/XMLSchema#string

Josiah E Petersen

http://www.w3.org/2001/XMLSchema#string

Julie M Decker

http://www.w3.org/2001/XMLSchema#string

Robert W Doms

http://www.w3.org/2001/XMLSchema#string

P2860

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

P304

8514-8527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00736-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Beatrice H. Hahn

Nicholas F Parrish

David C Montefiori

Joseph Sodroski

P577

2011-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51454085

http://www.w3.org/2001/XMLSchema#string

P698

21715507

http://www.w3.org/2001/XMLSchema#string

P921

HIV transmission

P932

3165820

http://www.w3.org/2001/XMLSchema#string